Thaci, D.; Menter, A.; Wu, J. J.; Arikan, D.; Kupper, H.; Bereswill, M.; Valdecantos, W. C. Long-Term Safety and Effectiveness of Adalimumab for Moderat-to-Severe Psoriasis: Results from the Eight-Year Interim Analysis of the ESPIRIT Registry. J of Skin 2017, 1, s22.